The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer

Liying Ma, Wenchu Lin|Journal of Experimental & Clinical Cancer Research|2020

Cited by 46